# Triptorelin for Ovary Protection in Childhood Onset Lupus

> **NCT00124514** · PHASE2 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 31 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** Triptorelin pamoate
- **DRUG:** Triptorelin Pamoate
- **DRUG:** Triptorelin Pamoate
- **DRUG:** Triptorelin Pamoate
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00124514
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2021-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00124514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00124514, "Triptorelin for Ovary Protection in Childhood Onset Lupus". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00124514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*